期刊文献+

不同影像检查方法对分化型甲状腺癌术后^(131)I清甲治疗疗效预测的研究进展

Research progress of different imaging methods in predicting the efficacy of ^(131)I ablation treatment in postoperative patients with differentiated thyroid carcinoma
原文传递
导出
摘要 分化型甲状腺癌(DTC)是最常见的头颈部恶性肿瘤之一,其清甲治疗疗效受残留甲状腺组织(以下简称残甲)的大小及其摄碘功能的影响。不同影像检查方法对残甲大小、摄碘功能的评估各有优缺点,对清甲治疗疗效也有不同的预测价值。部分SPECT/CT结合定量分析结果后可有效预测清甲治疗疗效。笔者综述了不同影像方法对DTC术后残甲大小和摄碘功能的评估以及^(131)I清甲治疗疗效的预测价值,以期为临床工作者提供更有效的诊疗依据。 Differentiated thyroid cancer(DTC)is one of the most common malignant tumors in the head and neck region,and the efficacy of ablation treatment is affected by the residual thyroid tissue size and its iodine uptake function.Different imaging methods have their own advantages and disadvantages in evaluating residual thyroid tissue size and iodine uptake function,and have different predictive values for the efficacy of ablation treatment.SPECT/CT combined with quantitative analysis results can effectively predict the efficacy of ablation treatment.The authors review the evaluation of residual thyroid tissue size and iodine uptake function after DTC surgery using different imaging methods,as well as the predictive value of ^(131)I therapy for the efficacy of ablation treatment,in order to provide more effective diagnostic and therapeutic basis for clinical workers.
作者 赵媛 马乐 王玉华 刘晔 张万春 Zhao Yuan;Ma Le;Wang Yuhua;Liu Ye;Zhang Wanchun(Major of Nuclear Medicine,Department of Medical Imaging,Shanxi Medical University,Taiyuan 030001,China;Department of Nuclear Medicine,Shanxi Bethune Hospital,Taiyuan 030032,China)
出处 《国际放射医学核医学杂志》 2024年第9期583-587,共5页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 甲状腺肿瘤 碘放射性同位素 放射性核素显像 全身显像 Thyroid neoplasms Iodine radioisotopes Radionuclide imaging Whole body imaging
  • 相关文献

参考文献10

二级参考文献89

  • 1彭李青,陈金品,李燕梅,曾麟春.螺旋CT三维重建与仿真喉镜在甲状腺疾病中的临床应用[J].中国临床医学影像杂志,2005,16(3):132-133. 被引量:2
  • 2施秉银.美国“甲状腺结节和分化性甲状腺癌的诊断治疗指南”解读(Ⅱ)[J].中华内分泌代谢杂志,2006,22(3):306-308. 被引量:8
  • 3lazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[J]. Am J Med, 1994,97(5) :418-428.
  • 4Nix P, Nicolaides A, Coatesworth AP. Thyroid cancer review 1: presentation and investigation of thyroid cancer [ J ]. Int J Clin Pract, 2005,59 ( 11 ) : 1340-1344.
  • 5Baudin E, Schlumberger M. New therapeutic approaches for meta- static thyroid carcinoma[ J]. Lancet Oncol, 2007,8 (2) : 148-156.
  • 6Eustatia-Rutten CF, Corssmit EP, Bierrnasz NR, et al. Survival and death causes in differentiated thyroid carcinoma[ J ]. J Clin Endocri- nol Metab, 2006,91 ( 1 ) :313-319.
  • 7Mazzaferri EL, Young RL, Oertel JE, et al. Papillary thyroid carci- noma: the impact of therapy in 576 patients [ J ]. Medicine ( Balti- more), 1977,56(3) :171-196.
  • 8Luster M, Clarke SE, Dietlein M, et al. Guidelines for radioiodine therapy of differentiated thyroid cancer[ J]. Eur J Nuel Med Mol Im- aging, 2008,35 ( 10 ) : 1941-1959.
  • 9Cooper DS, Doherty GM, Haugen BR, et al. Revised american thy- roid association management guidelines for patients with thyroid nod- ules and differentiated thyroid cancer[ J]. Thyroid, 2009,19 (11 ) : 1167-1214.
  • 10Karam M, Gianoukakis A, Feustel PJ, et aL Influence of diagnos- tic and therapeutic doses on thyroid remnant ablation rates[ J]. Nuel Med Commun, 2003,24(5) :489-495.

共引文献2381

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部